Literature DB >> 29775280

Fluorine Meets Amine: Reducing Microenvironment-Induced Amino-Activatable Nanoprobes for 19F-Magnetic Resonance Imaging of Biothiols.

Pingsheng Huang1, Weisheng Guo2, Guang Yang3, Huijuan Song1, Yuqing Wang2, Chun Wang1,4, Deling Kong1, Weiwei Wang1.   

Abstract

19F-magnetic resonance imaging (MRI) is of great significance for noninvasive imaging and detection of various diseases. However, the main obstacle in the application of 19F-MRI agents stems from the unmet signal sensitivity due to the poor water solubility and restricted mobility of segments with high number of fluorine atoms. Herein, we report a kind of intracellular reducing microenvironment-induced amino-activatable 19F-MRI nanoprobe, which can be used for specific imaging of biothiols. In principle, the nanoprobe has an initial architecture of hydrophobic core, where the trifluoromethyl-containing segments are compactly packed and 19F NMR/MRI signals are quenched ("OFF" state). Upon encountering sulfydryl, the strong electron-withdrawing 2,4-dinitrobenzenesulfonyl groups are excised to recover secondary amino groups, whose p Ka is proved to be 7.21. As a consequence, the molecular weight loss of the hydrophobic segment and the protonation of amino groups induce significant disturbance of hydrophilic/hydrophobic balance, leading to the disassembly of the nanoprobes and regain of spin-spin relaxation and 19F NMR/MRI signals ("ON" state, T2 up to 296 ± 5.3 ms). This nanoprobe shows high sensitivity and selectivity to biothiols, enabling intracellular and intratumoral imaging of glutathione. Our study not only provides a new nanoprobe candidate for biothiols imaging in vivo but also a promising strategy for the molecular design of real water-soluble and highly sensitive 19F-MRI nanoprobes.

Entities:  

Keywords:  19F-MRI; amino activation; nanoprobe; reducing microenvironment; thiol imaging

Mesh:

Substances:

Year:  2018        PMID: 29775280     DOI: 10.1021/acsami.8b03764

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

1.  A Fluorinated Ionic Liquid-Based Activatable 19F MRI Platform Detects Biological Targets.

Authors:  Xianglong Zhu; Xiaoxue Tang; Hongyu Lin; Saige Shi; Hehe Xiong; Qiuju Zhou; Ao Li; Qiaoyang Wang; Xiaoyuan Chen; Jinhao Gao
Journal:  Chem       Date:  2020-02-24       Impact factor: 22.804

2.  Protein-Engineered Nanoscale Micelles for Dynamic 19F Magnetic Resonance and Therapeutic Drug Delivery.

Authors:  Lindsay K Hill; Joseph A Frezzo; Priya Katyal; Dung Minh Hoang; Zakia Ben Youss Gironda; Cynthia Xu; Xuan Xie; Erika Delgado-Fukushima; Youssef Z Wadghiri; Jin Kim Montclare
Journal:  ACS Nano       Date:  2019-02-19       Impact factor: 15.881

Review 3.  Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.

Authors:  Joice Maria Joseph; Maria Rosa Gigliobianco; Bita Mahdavi Firouzabadi; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

4.  An Activatable 19 F MRI Molecular Probe for Sensing and Imaging of Norepinephrine.

Authors:  Lingxuan Li; Ao Li; Yaying Lin; Dongxia Chen; Bilun Kang; Hongyu Lin; Jinhao Gao
Journal:  ChemistryOpen       Date:  2022-06-28       Impact factor: 2.630

Review 5.  19 F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Authors:  Yanan Li; Jing Cui; Chenlong Li; Huimin Zhou; Jun Chang; Omer Aras; Feifei An
Journal:  ChemMedChem       Date:  2022-01-12       Impact factor: 3.540

Review 6.  The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.

Authors:  Lu Lu; Hongyuan Chen; Dake Hao; Xinke Zhang; Fengshan Wang
Journal:  Asian J Pharm Sci       Date:  2019-05-25       Impact factor: 6.598

Review 7.  Perfluorocarbons-Based 19F Magnetic Resonance Imaging in Biomedicine.

Authors:  Lina Wu; Fang Liu; Shuang Liu; Xiuan Xu; Zhaoxi Liu; Xilin Sun
Journal:  Int J Nanomedicine       Date:  2020-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.